Cargando…

Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma

BACKGROUND: Clinical studies implying the sunitinib multi-kinase inhibitor have led to disappointing results for breast cancer care but mostly focused on HER2-negative subtypes. Preclinical researches involving this drug mostly concern Triple Negative Breast Cancer (TNBC) murine models. Here, we exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thézé, Benoît, Bernards, Nicholas, Beynel, Audrey, Bouet, Stephan, Kuhnast, Bertrand, Buvat, Irène, Tavitian, Bertrand, Boisgard, Raphaël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511439/ https://www.ncbi.nlm.nih.gov/pubmed/26198000 http://dx.doi.org/10.1186/s12885-015-1540-2

Ejemplares similares

Fusion of [(18)F]FDG PET with Fluorescence Diffuse Optical Tomography to Improve Validation of Probes and Tumor Imaging
por: Garofalakis, Anikitos, et al.
Publicado: (2012)

In vivo Evaluation of Inflammatory Bowel Disease with the Aid of μPET and the Translocator Protein 18 kDa Radioligand [(18)F]DPA-714
por: Bernards, Nicholas, et al.
Publicado: (2014)

Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019)

Noninvasive evaluation of (18)F-FDG/(18)F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer
por: Zhang, Mingyu, et al.
Publicado: (2018)

The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo
por: Winkeler, Alexandra, et al.
Publicado: (2012)

Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer
por: Alberini, Jean-Louis, et al.
Publicado: (2015)

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO
por: Watanabe, Shiro, et al.
Publicado: (2019)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
por: Lee, Sze Ting, et al.
Publicado: (2021)

Novel [(18)F]-labeled thiol for the labeling of Dha- or maleimide-containing biomolecules
por: Richard, Mylène, et al.
Publicado: (2022)

[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021)

Comparison of (18)F-FES, (18)F-FDG, and (18)F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer
por: He, SiMin, et al.
Publicado: (2016)

Automated radiosynthesis of two (18)F-labeled tracers containing 3-fluoro-2-hydroxypropyl moiety, [(18)F]FMISO and [(18)F]PM-PBB3, via [(18)F]epifluorohydrin
por: Ohkubo, Takayuki, et al.
Publicado: (2021)

Kinetic Evaluation of the Hypoxia Radiotracers [(18)F]FMISO and [(18)F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging
por: Choen, Sangkyung, et al.
Publicado: (2022)

[(18)F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer
por: Yamane, Tomohiko, et al.
Publicado: (2019)

Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
por: Shimizu, Yoichi, et al.
Publicado: (2021)

(18)F-FDG—PET/CT in Canine Mammary Gland Tumors
por: Sánchez, Diana, et al.
Publicado: (2019)

[(18)F]DPA-714 as a biomarker for positron emission tomography imaging of rheumatoid arthritis in an animal model
por: Pottier, Géraldine, et al.
Publicado: (2014)

Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy
por: Tong, Xiao, et al.
Publicado: (2016)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
por: Aogi, Kenjiro, et al.
Publicado: (2015)

Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
por: Ching, Alex Sik Chung, et al.
Publicado: (2011)

Elimination of tumor hypoxia by eribulin demonstrated by (18)F-FMISO hypoxia imaging in human tumor xenograft models
por: Zhao, Songji, et al.
Publicado: (2019)

18F-FDG 18F-FDG Positron Emission Tomography Imaging of Cortical Reorganization in Spinal Trauma
por: Chopra, Jigyasa, et al.
Publicado: (2022)

Influence of age on radiomic features in (18)F-FDG PET in normal breast tissue and in breast cancer tumors
por: Boughdad, Sarah, et al.
Publicado: (2018)

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using (18)F-FMISO-PET
por: Rockne, Russell C., et al.
Publicado: (2015)

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and (18)F-FMISO PET
por: Huang, Shiliang, et al.
Publicado: (2021)

Synthesis of [(18)F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
por: Kniess, Torsten, et al.
Publicado: (2023)

Isotopic Radiolabeling of the Antiretroviral Drug [(18)F]Dolutegravir for Pharmacokinetic PET Imaging
por: Tisseraud, Marion, et al.
Publicado: (2022)

Hypoxia is important in F-18 FDG accumulation in thecoma-fibroma tumors on F-18 FDG PET/CT scans
por: SEINO, HIROKO, et al.
Publicado: (2016)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

The role of necrosis, acute hypoxia and chronic hypoxia in (18)F-FMISO PET image contrast: a computational modelling study
por: Warren, Daniel R, et al.
Publicado: (2016)

Repurposing (18)F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2021)

(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)

18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer
por: Soydal, Çiğdem, et al.
Publicado: (2015)

18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer
por: Orlhac, Fanny, et al.
Publicado: (2015)

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients
por: Birsen, Rudy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qnov8v79kcabecel0sd3157222